Association of Endotoxemia and Endothelin-1 With Development of Cardiac Allograft Vasculopathy After Heart Transplantation

被引:0
|
作者
Braghieri, Lorenzo
Bohn, Bruno
Mondellini, Giulio
Javaid, Azka
Kim, Andrea J.
Onat, Hatice D.
Latif, Farhana
Farr, Maryjane
Sayer, Gabriel T.
Uriel, Nir
Takeda, Koji
Naka, Yoshifumi
Demmer, Ryan
Colombo, Paolo C.
Yuzefpolskaya, Melana
机构
关键词
D O I
10.1161/circ.142.suppl_3.17120
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A17120
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation and association with mortality: a population-based study
    Bonnet, G.
    Coutance, G.
    Van Keer, J.
    Raynaud, M.
    Aubert, O.
    Bories, M. C.
    Bruneval, P.
    Varnous, S.
    Leprince, P.
    Empana, J. P.
    Naesens, M.
    Patel, J. K.
    Loupy, A.
    Kobashigawa, J.
    Jouven, X.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1105 - 1105
  • [32] The Role of Cardiac Rehabilitation after Heart Transplantation in the Reduction of Cardiac Allograft Vasculopathy.
    Kittleson, M.
    Patel, J.
    Rafiei, M.
    Osborne, A.
    Chang, D.
    Czer, L.
    Kobashigawa, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 452 - 452
  • [33] BENEFIT OF TACROLIMUS/MYCOPHENOLATE TO REDUCE CARDIAC ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION
    Aaronson, Alistair
    Kittleson, Michelle
    Patel, Jignesh
    Rafiei, Matthew
    Osborne, Ashley
    Chang, David
    Czer, Lawrence
    Kobashigawa, Jon
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E798 - E798
  • [34] IDENTIFICATION AND DETERMINANTS OF CARDIAC ALLOGRAFT VASCULOPATHY (CAV) TRAJECTORIES AFTER HEART TRANSPLANTATION
    Bonnet, Guillaume
    Coutance, Guillaume
    Racape, Maud
    Raynaud, Marc
    van Keer, Jan
    Bories, Marie-Cecile
    Varnous, Shaida
    Rouvier, Philippe
    Guillemain, Romain
    Lecuyer, Lucien
    Bruneval, Patrick
    Duong-Van-Huyen, Jean-Paul
    Taupin, Jean-Luc
    Naesens, Maarten
    Lefaucheur, Carmen
    Jouven, Xavier
    Kobashigawa, Jon
    Loupy, Alexandre
    TRANSPLANT INTERNATIONAL, 2019, 32 : 391 - 391
  • [35] Changes in Myocardial Microvascularisation After Heart Transplantation and During Cardiac Allograft Vasculopathy
    Huibers, M.
    van Pijpen, E.
    Kirkels, H.
    de Jonge, N.
    Vink, A.
    de Weger, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S136 - S136
  • [36] Transforming growth factor β in relation to cardiac allograft vasculopathy after heart transplantation
    Aziz, T
    Hasleton, P
    Hann, AW
    Yonan, N
    Deiraniya, A
    Hutchinson, IV
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2000, 119 (04): : 700 - 707
  • [37] Uric Acid is an Independent Predictor of Cardiac Allograft Vasculopathy After Heart Transplantation
    Asleh, Rabea
    Prasad, Megha
    Briasoulis, Alexandros
    Boilson, Barry A.
    Edwards, Brooks S.
    Clavell, Alfredo L.
    Pereira, Naveen L.
    Adigun, Rosalyn
    Simon, Maltais
    Daly, Richard C.
    Lerman, Amir
    Kushwaha, Sudhir S.
    CIRCULATION, 2017, 136
  • [38] Incidence, progression and functional significance of cardiac allograft vasculopathy after heart transplantation
    Julius, BK
    Jost, CHA
    Sütsch, G
    Brunner, HP
    Kuenzli, A
    Vogt, PR
    Turina, M
    Hess, OM
    Kiowski, W
    TRANSPLANTATION, 2000, 69 (05) : 847 - 853
  • [39] Validation of the Cardiac Allograft Vasculopathy (CAV) Trajectory Score after Heart Transplantation
    Patel, N.
    Kittleson, M.
    Chang, D.
    Patel, J.
    Azarbal, B.
    Singer-Englar, T.
    Geft, D.
    Czer, L.
    Esmailian, F.
    Kobashigawa, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S205 - S205
  • [40] Expression of iNOSmRNA to prevent cardiac allograft vasculopathy after heart transplantation in rat
    吴乃石
    藏旺福
    张科峰
    张明宇
    姚志发
    ChinaMedicalAbstracts, 2005, (04) : 293 - 296